Summary

Nanobody Trends and Forecast
The future of the global nanobody market looks promising with opportunities in the therapeutic, diagnostic, and research markets. The global nanobody market is expected to reach an estimated $2.8 billion by 2030 with a CAGR of 24.7% from 2024 to 2030. The major drivers for this market are surging interest in precision medicine and elevating support for nanobody research and development.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Nanobody by Segment
The study includes a forecast for the global nanobody by type, application, end use, and region.

Nanobody Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Mono-Specific
• Multi-Specific

Nanobody Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Therapeutic
• Diagnostic
• Research

Nanobody Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Pharmaceutical & Biotechnology Companies
• Research Laboratories
• Others

Nanobody Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Nanobody Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nanobody companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nanobody companies profiled in this report include-
• Sanofi
• Merck KGaA
• BIOCYTOGEN
• Proteintech
• Novartis
• GenScript
• Sensei Biotherapeutics
• Beroni
• ExeVir Bio
• Taisho Pharmaceutical


Nanobody Market Insights
Lucintel forecasts that mono-specific is expected to witness the higher growth over the forecast period due to escalating presence of diverse cancer types.
Within this market, research will remain the largest segment due to growing adoption of nanobodies by pharmaceutical companies.
North America will remain the largest region over the forecast period due to high awareness associated with nanobodies technology.

Features of the Global Nanobody Market

Market Size Estimates: Nanobody market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Nanobody market size by type, application, end use, and region in terms of value ($B).
Regional Analysis: Nanobody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the nanobody market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nanobody market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the nanobody market size?
Answer: The global nanobody market is expected to reach an estimated $2.8 billion by 2030.

Q2. What is the growth forecast for nanobody market?
Answer: The global nanobody market is expected to grow with a CAGR of 24.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the nanobody market?
Answer: The major drivers for this market are surging interest in precision medicine and elevating support for nanobody research and development.

Q4. What are the major segments for nanobody market?
Answer: The future of the nanobody market looks promising with opportunities in the therapeutic, diagnostic, and research markets.

Q5. Who are the key nanobody market companies?
Answer: Some of the key nanobody companies are as follows:
• Sanofi
• Merck KGaA
• BIOCYTOGEN
• Proteintech
• Novartis
• GenScript
• Sensei Biotherapeutics
• Beroni
• ExeVir Bio
• Taisho Pharmaceutical



Q6. Which nanobody market segment will be the largest in future?
Answer: Lucintel forecasts that mono-specific is expected to witness the higher growth over the forecast period due to escalating presence of diverse cancer types.

Q7. In nanobody market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high awareness associated with nanobodies technology.

Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the nanobody market by type (mono-specific and multi-specific), application (therapeutic, diagnostic, and research), end use (pharmaceutical & biotechnology companies, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

ページTOPに戻る

Table of Contents